MGC’s collaboration with RMIT has led to two major projects in the field of data collection, a crucial element for MGC’s clinical program and for the Phytocannabinoid industry as a whole, where there is a significant dearth of knowledge and data, responsibly collected and maintained, to be used for future product development, health and safety studies, and much more.
The ‘CannEpil®’ app is intended to be used by person (or the guardian of the person) taking CannEpil® as a prescription treatment.
This App is a cross platform application available to download both from App Store and Play Store. It is intended to record patient responses to medical questionnaires which the patient is required to complete as part of their treatment. The Treating Practitioner will be able to view the responses to the medical questionnaires that the patients record in the App thereby allowing them to monitor the treatment in real time. The App will make it easy for the Treating Practitioners and MGC Pharma to evaluate and report the efficacy of CannEpil®.
The International Library of Cannabinoids (ILC) is a web-based application that provides an integrated and open source platform for cannabinoid research/user data from academia, industry and clinicians. The vision is that all cannabinoid research/user data will be deposited in a common repository and overtime this repository will provide evidence for efficacy of cannabinoid treatment of various disorders, and help doctors, researchers and industry to choose the right cannabinoid profiles for various conditions.
International Library of Cannabinoids